Literature DB >> 25059667

Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33.

Akiko Ishida1, Kaoru Akita1, Yugo Mori1, Shuhei Tanida1, Munetoyo Toda1, Mizue Inoue1, Hiroshi Nakada2.   

Abstract

When monocyte-derived immature dendritic cells (imDCs) were stimulated with LPS in the presence of anti-CD33/Siglec-3 mAb, the production of IL-12 and phosphorylation of NF-κB decreased significantly. The cell surface proteins of imDCs were chemically cross-linked, and CD33-linked proteins were analyzed by SDS-PAGE and immunoblotting. It was CD14 that was found to be cross-linked with CD33. A proximity ligation assay also indicated that CD33 was colocalized with CD14 on the cell surface of imDCs. Sialic acid-dependent binding of CD33 to CD14 was confirmed by a plate assay using recombinant CD33 and CD14. Three types of cells (HEK293T cells expressing the LPS receptor complex (Toll-like receptor (TLR) cells), and the LPS receptor complex plus either wild-type CD33 (TLR/CD33WT cells) or mutated CD33 without sialic acid-binding activity (TLR/CD33RA cells)) were prepared, and then the binding and uptake of LPS were investigated. Although the level of LPS bound on the cell surface was similar among these cells, the uptake of LPS was reduced in TLR/CD33WT cells. A higher level of CD14-bound LPS and a lower level of TLR4-bound LPS were detected in TLR/CD33WT cells compared with the other two cell types, probably due to reduced presentation of LPS from CD14 to TLR4. Phosphorylation of NF-κB after stimulation with LPS was also compared. Wild-type CD33 but not mutated CD33 significantly reduced the phosphorylation of NF-κB. These results suggest that CD14 is an endogenous ligand for CD33 and that ligation of CD33 with CD14 modulates with the presentation of LPS from CD14 to TLR4, leading to down-regulation of TLR4-mediated signaling.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Dendritic Cell; Innate Immunity; Lectin; NF-kappaB; Signaling; Toll-like Receptor (TLR)

Mesh:

Substances:

Year:  2014        PMID: 25059667      PMCID: PMC4155695          DOI: 10.1074/jbc.M113.523480

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.

Authors:  J da Silva Correia; K Soldau; U Christen; P S Tobias; R J Ulevitch
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

2.  Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane.

Authors:  Martha Triantafilou; Siegfried Morath; Alan Mackie; Thomas Hartung; Kathy Triantafilou
Journal:  J Cell Sci       Date:  2004-08-01       Impact factor: 5.285

3.  Phosphatidylserine regulates the maturation of human dendritic cells.

Authors:  Xiao Chen; Kara Doffek; Sonia L Sugg; Joel Shilyansky
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

4.  Drosophila Toll and IL-1 receptor.

Authors:  N J Gay; F J Keith
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

5.  Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells.

Authors:  D Simmons; B Seed
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

6.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

7.  CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes.

Authors:  E Ferrero; C L Hsieh; U Francke; S M Goyert
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

8.  Divergent response to LPS and bacteria in CD14-deficient murine macrophages.

Authors:  K J Moore; L P Andersson; R R Ingalls; B G Monks; R Li; M A Arnaout; D T Golenbock; M W Freeman
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

9.  Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations.

Authors:  Theresa L Gioannini; Athmane Teghanemt; DeSheng Zhang; Nathan P Coussens; Wendie Dockstader; S Ramaswamy; Jerrold P Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

10.  Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites.

Authors:  N Mackman; K Brand; T S Edgington
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  22 in total

1.  Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Authors:  Flavio Schwarz; Stevan A Springer; Tasha K Altheide; Nissi M Varki; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

2.  Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.

Authors:  Miriam Y Kim; Kyung-Rok Yu; Saad S Kenderian; Marco Ruella; Shirley Chen; Tae-Hoon Shin; Aisha A Aljanahi; Daniel Schreeder; Michael Klichinsky; Olga Shestova; Miroslaw S Kozlowski; Katherine D Cummins; Xinhe Shan; Maksim Shestov; Adam Bagg; Jennifer J D Morrissette; Palak Sekhri; Cicera R Lazzarotto; Katherine R Calvo; Douglas B Kuhns; Robert E Donahue; Gregory K Behbehani; Shengdar Q Tsai; Cynthia E Dunbar; Saar Gill
Journal:  Cell       Date:  2018-05-31       Impact factor: 41.582

3.  Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.

Authors:  Douglas G Walker; Alexis M Whetzel; Geidy Serrano; Lucia I Sue; Thomas G Beach; Lih-Fen Lue
Journal:  Neurobiol Aging       Date:  2014-10-02       Impact factor: 4.673

4.  TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.

Authors:  Ana Griciuc; Shaun Patel; Anthony N Federico; Se Hoon Choi; Brendan J Innes; Mary K Oram; Gea Cereghetti; Danielle McGinty; Anthony Anselmo; Ruslan I Sadreyev; Suzanne E Hickman; Joseph El Khoury; Marco Colonna; Rudolph E Tanzi
Journal:  Neuron       Date:  2019-07-10       Impact factor: 17.173

5.  CD13 restricts TLR4 endocytic signal transduction in inflammation.

Authors:  Mallika Ghosh; Jaganathan Subramani; M Mamunur Rahman; Linda H Shapiro
Journal:  J Immunol       Date:  2015-03-23       Impact factor: 5.422

6.  Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.

Authors:  Jerry J Fong; Karthik Sreedhara; Liwen Deng; Nissi M Varki; Takashi Angata; Qinglian Liu; Victor Nizet; Ajit Varki
Journal:  EMBO J       Date:  2015-10-12       Impact factor: 11.598

7.  The role of neuraminidase in TLR4-MAPK signalling and the release of cytokines by lupus serum-stimulated mesangial cells.

Authors:  Kamala Sundararaj; Jessalyn Rodgers; Peggi Angel; Bethany Wolf; Tamara K Nowling
Journal:  Immunology       Date:  2021-01-24       Impact factor: 7.397

8.  Modulation of immune cell reactivity with cis-binding Siglec agonists.

Authors:  Corleone S Delaveris; Shannon H Chiu; Nicholas M Riley; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

9.  Gut Microbiome and Colon Cancer: Role of Bacterial Metabolites and Their Molecular Targets in the Host.

Authors:  Yangzom D Bhutia; Jiro Ogura; Sathish Sivaprakasam; Vadivel Ganapathy
Journal:  Curr Colorectal Cancer Rep       Date:  2017-02-22

10.  Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.

Authors:  Manasi Malik; Joe Chiles; Hualin S Xi; Christopher Medway; James Simpson; Shobha Potluri; Dianna Howard; Ying Liang; Christian M Paumi; Shubhabrata Mukherjee; Paul Crane; Steven Younkin; David W Fardo; Steven Estus
Journal:  Hum Mol Genet       Date:  2015-03-11       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.